Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy

NCT02834663 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Nonproliferative Diabetic Retinopathy

Interventions

DRUG: Lucentis

Sponsor

Wonkwang University Hospital

Collaborators

[object Object]